Mounting evidence from medical research suggests entheogens like psilocybin and MDMA may be powerful therapeutic tools in the fight against mental illness and depression. Cities and states across the country are rewriting local laws and policies to expand public access to these substances,  and in turn, burgeoning new industries have entered the marketplace. 

Sick Legal works directly with policymakers and change agents to efficiently and sensibly deliver the benefits of this research to their communities. Our depth of knowledge and experience in decriminalization and regulation of previously controlled substances empowers government and medical entities to safely navigate the often-times confusing policy waters between federal, state and local jurisdictions. 

Our work also engages non-profits, entrepreneurs, advocates, and churches in the sphere. We help our clients craft and execute tactical strategies and reform movements that capitalize on this growing body of cutting-edge research while ensuring your project is legally secured as the complex regulatory landscape shifts.

Our services in the entheogen legal space include:

• Organization and non-profit incorporation

• Religious organization formation and protections

• Constitutional law advising, including religious use exemptions and First Amendment rights

• Lobbying advising

• Legislation drafting services

• Legislative advising

• Food & Drug Administration (FDA) and Drug Enforcement Administration (DEA) regulatory advising

• Regulatory compliance

• Risk Assessments for practitioners and other health care professionals

• Assisting organizations in drafting ethical guidelines for practitioners